R.J.P. has nothing to disclose. B.C.J.M.F. has received fees and grant support from Actavis, COGI, Euroscreen, Ferring, Genovum, Preglem, Gedeon-Richter, Merck Serono, Ova-Science, Pantharel Bioscience, Roche, Uteron, Watson Laboratories, Finox, Netherlands Genomics Initiative, Hartstichting, and UMC Utrecht. L.T.N.V. has nothing to disclose. K.D. owns restricted stock in INVO Bioscience.
© 2016 American Society for Reproductive Medicine. Published by Elsevier Inc.